个人概况
姓名:邢艳芳 性别:女
职称:副主任医师 导师资格:硕士研究生导师
单位:广州医科大学附属第三医院 专业:肾内科学
学历:研究生 毕业院校:中山大学
电子邮件:2574410512@qq.com
通信地址:广州市荔湾区多宝路63号
研究方向
慢性肾脏病对免疫系统的影响及机制,及慢性肾脏病并发症方面的研究。
所获荣誉
1.广州市高层次卫生人才骨干项目
2.广州医科大学附属第三医院精英人才计划
3.广州医科大学附属第三医院毅文人才工程
科研项目
1. 国家自然科学基金面上项目1项
2. 国家自然科学基金青年科学基金项目1项
3. 广东省自然科学基金面上项目2项
4. 广州市属高校科研项目1项
5. 广州医科大学青年项目 1项
代表性第一和通讯作者论文:
1) Xing YF#,*, Cai JR#, Qin JJ#, Zhou WY, Li CM, Li X*. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events. Front Immunol.2021 Jan 29;11:577253.
2) Qin JJ# , Xing YF*,# , Ren JH# , Chen YJ, Gan YF, Jiang YQ, Chen J*, Li X*. Mandatory Mask-Wearing and Hand Hygiene Associated With Decreased Infectious Diseases Among Patients Undergoing Regular Hemodialysis: A Historical-Control Study. Front Public Health. 2021 Jun 29;9:678738.
3) Li X#,*, Chen J#, Chen YJ#, Qiao YD, Zhao LY, Jiang N, Wu XY*, Xing YF*.Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion. Commun Biol.2021 Feb 26;4(1):252.
4) Li X#, Li JL#, Jiang N#, Chen J, Liang ZM, Zhao ZL*, Xing YF*. Accumulation of LOX-1+PMN-MDSCs in nasopharyngeal carcinoma survivors with chronic hepatitis B might permit immune tolerance to epstein-barr virus and relate to tumor recurrence. Aging (Albany NY). 2021 Jan 15;13(1):437-449.
5) Cai R, Wu M, Lin M, Guo X, Xing Y*. Pretransplant Homeostasis Model Assessment of Insulin Resistance and Fasting Plasma Glucose Predict New-Onset Diabetes After Renal Transplant in Chinese Patients. Transplant Proc. 2019 Apr;51(3):768-773.
6) Cai R, Wu M, Xing Y*. Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant. Ther Clin Risk Manag. 2019 Mar 14;15:497-503.
7) Nan J#, Xing YF#, Hu B#, Tang JX, Dong HM, He YM, Ruan DY, Ye QJ, Cai JR, Ma XK, Chen J, Cai XR, Lin ZX, Wu XY*, Li X*. Endoplasmic reticulum stress induced Lox-1+CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma. Immunology. 2018 May;154(1):144-155.
8) Xing YF#, Cai RM#, Lin Q#, Ye QJ, Ren JH, Yin LH, Li X*. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications. Kidney Int. 2017 May;91(5):1236-1242.